Nevertheless, CRC tumours are typically heterogenous, consisting of multiple genetically different clones, some of which carry wild type forms of these oncogenes, even within tumours that are resistant to EGFR‐targeting chemotherapies (Misale et al., 2012). This evidence concerns the gene EGFR and colorectal carcinoma.